Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Secondary Erythrocytosis Is Phenotypically Distinct from Polycythemia Vera but Associated with Comparable Rates of Thrombosis at Diagnosis

Eliane Nguyen, MD, Natasha Szuber, MD, Michael Harnois, Lambert Busque, MD, Luigina Mollica, MD FRCPC, PhD, Sarit E Assouline, MD MSc, Ines Chamakhi, MD MD FRCP(C), Harold J. Olney, MD, Shireen Sirhan, MD

Blood (2020) 136 (Supplement 1): 4–7.

https://doi.org/10.1182/blood-2020-141835

Published: 2020

Journal Articles

Timely Molecular Monitoring and Achievement of Major Molecular Response in Chronic Myeloid Leukemia

Adi J. Klil-Drori, MD, Laurent Azoulay, PhD, Hui Yin, MSc, Alexa Del Corpo, Michaël Harnois, MSc, Michel-Olivier Gratton, MSc, Ines Chamakhi, MD, Robert Delage, MD MSc, FRCP, Luigina Mollica, MD PhD, Pierre Laneuville, MD FRCPC, Harold J. Olney, MD CM, Lambert Busque, MD, Sarit E. Assouline, MDMSc

Blood (2016) 128 (22): 3072.

https://doi.org/10.1182/blood.V128.22.3072.3072

Published: 2016

Journal Articles

Descriptive Analysis of Azacitidine Use in Four Adult University Teaching Hospitals in Quebec, Canada

Ghislain Bérard, B.Pharm. M. Sc, Nathalie Marcotte, B.Pharm, MSc, Marie-Claude Michel, Paul Farand, MD, Louise Deschenes, MD, Daniel Froment, MD, France Varin, Pierre Gaudreault, MD, Elaine Pelletier, Chantal Guévremont, Raghu Rajan, MD, Nathalie Letarte, BPharm, MSc, BCOP, Harold J. Olney, MD CM

Blood (2015) 126 (23): 5244.

https://doi.org/10.1182/blood.V126.23.5244.5244

Published: 2015

Journal Articles

Comparative Effectiveness of Generic Imatinib and Brand-Name Imatinib for the Treatment of Chronic Myeloid Leukemia

Adi J Klil-Drori, MD, Laurent Azoulay, PhD, Hui Yin, MSc, Michel-Olivier Gratton, MSc, Michaël Harnois, MSc, Ines Chamakhi, MD, Robert Delage, MD MSc, FRCP, Pierre Laneuville, MD FRCPC, Luigina Mollica, MD FRCPC, PhD, Harold J. Olney, MD CM, Lambert Busque, MD, Sarit E. Assouline, MDMSc

Blood (2015) 126 (23): 2778.

https://doi.org/10.1182/blood.V126.23.2778.2778

Published: 2015

Journal Articles

A Randomized Trial Of Rituximab Vs Observation Following Autologous Stem Cell Transplantation (ASCT) For Relapsed Or Refractory CD20-Positive B Cell Lymphoma: Final Results Of NCIC CTG LY.12

Blood (2013) 122 (21): 155.

https://doi.org/10.1182/blood.V122.21.155.155

Published: 2013

Journal Articles

Gemcitabine, Dexamethasone, Cisplatin (GDP) Compared to Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Prior to Autologous Stem Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: Final Results of the Randomized Phase III NCIC CTG Study LY12

Blood (2012) 120 (21): 745.

https://doi.org/10.1182/blood.V120.21.745.745

Published: 2012

Journal Articles

Efficacy and Safety of Eltrombopag in Elderly Patients with Chronic Immune Thrombocytopenia: Analysis of Five Clinical Trials,

Harold J. Olney, MD, Ingrid Pabinger, MD, Bhabita Mayer, MSc, Kalpana Bakshi, BS, MS, Christine K Bailey, PhD, Andres Brainsky, MD

Blood (2011) 118 (21): 3294.

https://doi.org/10.1182/blood.V118.21.3294.3294

Published: 2011

Journal Articles

Efficacy of Eltrombopag In Splenectomized Versus Nonsplenectomized Patients with Chronic ITP In the RAISE Study

Harold J. Olney, MD, CM, FRCP (C), Patrick F. Fogarty, MD, Michael D. Tarantino, MD, Bhabita Mayer, MSc, Sandra Y. Vasey, MS, Andres Brainsky, MD

Blood (2010) 116 (21): 2512.

https://doi.org/10.1182/blood.V116.21.2512.2512

Published: 2010

Journal Articles

Time to Splenectomy Failure in Patients with Recurrent or Refractory Chronic Immune Thrombocytopenic Purpura.

Gregory Cheng, Terry Gernsheimer, MD, Harold J. Olney, MD, CM, James B. Bussel, MD, Palvi Shah, Andres Brainsky, Kelly M. Grotzinger, Manuel Aivado

Blood (2009) 114 (22): 3522.

https://doi.org/10.1182/blood.V114.22.3522.3522

Published: 2009

Journal Articles

D-DImer Dosing for Risk Prediction of Central Venous Catheter Thrombosis (The DIReCT Trial).

Stephane Doucet, MD, Marie-Jose Miron, MD, Soulieres Denis, MD, Belanger Karl, MD, Florescu Marie, MD, Ayoub Jean-Pierre, MD, Yelle Louise, MD, Harold J. Olney, MD, Normand Blais, MD

Blood (2007) 110 (11): 3980.

https://doi.org/10.1182/blood.V110.11.3980.3980

Published: 2007

Journal Articles

Prevalence of Frequent α-Globin Gene Deletions in Neonates with HbH in Cord Blood.

Celine Devaux, MD, Xiaoduan Weng, PhD, Louise Robin, TM, Harold J. Olney, MD, Gilbert Cornut, Denis Soulières, MD, MSc

Blood (2005) 106 (11): 3817.

https://doi.org/10.1182/blood.V106.11.3817.3817

Published: 2005

Journal Articles

Influence of α and β-Globin Mutations on Ineffective Erythropoiesis in β-Thalassemia Minor Cases.

Gilbert Cornut, Xiaoduan Weng, PhD, Harold J. Olney, MD, Louise Robin, TM, Sylvain Marchand, MSc, Catherine Lavoie, MD, Denis Soulières, MD, MSc

Blood (2005) 106 (11): 3818.

https://doi.org/10.1182/blood.V106.11.3818.3818

Published: 2005

Journal Articles

Prevelence of α-Globin Deletions in β-Thalassemia Minor Patients and Differences in Erythrocyte Indices.

Denis Soulieres, MD, MSc, Sylvain Marchand, TM, BSc, Xiaoduan Weng, MD, PhD, Julie Bergeron, MD, Louise Robin, TM, Harold J. Olney, MD

Blood (2004) 104 (11): 3761.

https://doi.org/10.1182/blood.V104.11.3761.3761

Published: 2004

Journal Articles

Prevalence of Alpha-Globin Gene Deletions amongst Patients with Unexplained Microcytosis in a North-American Population.

Julie Bergeron, MD, Xiaoduan Weng, MD, PhD, Louise Robin, TM, Harold J. Olney, MD, CM, Denis Soulières, MD, MSc

Blood (2004) 104 (11): 3762.

https://doi.org/10.1182/blood.V104.11.3762.3762

Published: 2004

NARROW

Secondary Erythrocytosis Is Phenotypically Distinct from Polycythemia Vera but Associated with Comparable Rates of Thrombosis at Diagnosis

Timely Molecular Monitoring and Achievement of Major Molecular Response in Chronic Myeloid Leukemia

Descriptive Analysis of Azacitidine Use in Four Adult University Teaching Hospitals in Quebec, Canada

Comparative Effectiveness of Generic Imatinib and Brand-Name Imatinib for the Treatment of Chronic Myeloid Leukemia

A Randomized Trial Of Rituximab Vs Observation Following Autologous Stem Cell Transplantation (ASCT) For Relapsed Or Refractory CD20-Positive B Cell Lymphoma: Final Results Of NCIC CTG LY.12

Gemcitabine, Dexamethasone, Cisplatin (GDP) Compared to Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Prior to Autologous Stem Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: Final Results of the Randomized Phase III NCIC CTG Study LY12

Efficacy and Safety of Eltrombopag in Elderly Patients with Chronic Immune Thrombocytopenia: Analysis of Five Clinical Trials,

Efficacy of Eltrombopag In Splenectomized Versus Nonsplenectomized Patients with Chronic ITP In the RAISE Study

Time to Splenectomy Failure in Patients with Recurrent or Refractory Chronic Immune Thrombocytopenic Purpura.

D-DImer Dosing for Risk Prediction of Central Venous Catheter Thrombosis (The DIReCT Trial).

Prevalence of Frequent α-Globin Gene Deletions in Neonates with HbH in Cord Blood.

Influence of α and β-Globin Mutations on Ineffective Erythropoiesis in β-Thalassemia Minor Cases.

Prevelence of α-Globin Deletions in β-Thalassemia Minor Patients and Differences in Erythrocyte Indices.

Prevalence of Alpha-Globin Gene Deletions amongst Patients with Unexplained Microcytosis in a North-American Population.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only